New obesity drug VK2735 enters final testing phase
NCT ID NCT07104500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called VK2735, given as a weekly injection, to help people with obesity or overweight lose weight. About 4500 adults without diabetes will receive either the drug or a placebo for 78 weeks. The main goal is to see how much weight they lose and if the drug is safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 4,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥18 years of age at the time of signing the informed consent 2. Body mass index (BMI) ≥30 kg/m2 OR ≥27 kg/m2 with at least one weight-related co- morbid condition (treated or untreated) * Weight-related co-morbid conditions include hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease * Cardiovascular disease includes, for example, ischemic cardiovascular disease, New York Heart Association (NYHA) Functional Class I-III heart failure * BMI calculated at the Screening visit will be used to determine eligibility Exclusion Criteria: 1. History of or current clinically significant medical disorder that, in the opinion of the Investigator, does not support study participation 2. Self-reported body weight change of 5% or more within 3 months of screening 3. Have a prior or planned surgical treatment for obesity (excluding liposuction or abdominoplasty if performed \>1 year prior to screening) 4. Have or plan to have endoscopic and/or device-based therapy for obesity or have had device removal within the last 6 months prior to screening (such as, mucosa ablation, gastric artery embolization, intragastric balloon, duodenal-jejunal endoluminal line) 5. Current or past diagnosis of diabetes mellitus (including type 1, type 2, except gestational diabetes) 6. Treatment with glucose-lowering agent(s) within 90 days before screening 7. Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) 8. History of acute or chronic pancreatitis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Viking Clinical Site #1001
Methuen, Massachusetts, 01844, United States
-
Viking Clinical Site #1002
Ogden, Utah, 84405, United States
-
Viking Clinical Site #1003
Cooper City, Florida, 33024, United States
-
Viking Clinical Site #1004
Knoxville, Tennessee, 37909, United States
-
Viking Clinical Site #1005
Chandler, Arizona, 85210, United States
-
Viking Clinical Site #1006
Chicago, Illinois, 60607, United States
-
Viking Clinical Site #1007
Austin, Texas, 78705, United States
-
Viking Clinical Site #1008
Nashville, Tennessee, 37203, United States
-
Viking Clinical Site #1009
Louisville, Kentucky, 40213, United States
-
Viking Clinical Site #1010
Butte, Montana, 59701, United States
-
Viking Clinical Site #1011
Port Orange, Florida, 32127, United States
-
Viking Clinical Site #1012
Ocoee, Florida, 34761, United States
-
Viking Clinical Site #1013
Clearwater, Florida, 33756, United States
-
Viking Clinical Site #1014
Lake Forest, California, 92630, United States
-
Viking Clinical Site #1016
Kansas City, Missouri, 64131, United States
-
Viking Clinical Site #1017
Flagstaff, Arizona, 86001, United States
-
Viking Clinical Site #1018
Peoria, Arizona, 85381, United States
-
Viking Clinical Site #1019
Tucson, Arizona, 85711, United States
-
Viking Clinical Site #1020
Metairie, Louisiana, 70006, United States
-
Viking Clinical Site #1021
The Bronx, New York, 10455, United States
-
Viking Clinical Site #1022
West Des Moines, Iowa, 50266, United States
-
Viking Clinical Site #1023
North Charleston, South Carolina, 29405, United States
-
Viking Clinical Site #1024
St. George, Utah, 84790, United States
-
Viking Clinical Site #1025
Woodstock, Georgia, 30189, United States
-
Viking Clinical Site #1026
Greensboro, North Carolina, 27410, United States
-
Viking Clinical Site #1027
Fargo, North Dakota, 58104, United States
-
Viking Clinical Site #1028
Greenville, South Carolina, 29607, United States
-
Viking Clinical Site #1029
Albuquerque, New Mexico, 87109, United States
-
Viking Clinical Site #1030
Columbus, Georgia, 31904, United States
-
Viking Clinical Site #1031
City of Saint Peters, Missouri, 63303, United States
-
Viking Clinical Site #1032
Westfield, New York, 14787, United States
-
Viking Clinical Site #1034
Reno, Nevada, 89511, United States
-
Viking Clinical Site #1035
Las Vegas, Nevada, 89148, United States
-
Viking Clinical Site #1036
Little Rock, Arkansas, 72211, United States
-
Viking Clinical Site #1037
Birmingham, Alabama, 35235, United States
-
Viking Clinical Site #1038
Ypsilanti, Michigan, 48197, United States
-
Viking Clinical Site #1039
Sandy City, Utah, 84094, United States
-
Viking Clinical Site #1040
Lexington, Kentucky, 40513, United States
-
Viking Clinical Site #1041
Spokane, Washington, 99218, United States
-
Viking Clinical Site #1042
East Syracuse, New York, 13057, United States
-
Viking Clinical Site #1043
Cincinnati, Ohio, 45219, United States
-
Viking Clinical Site #1044
Cleveland, Ohio, 44122, United States
-
Viking Clinical Site #1045
East Greenwich, Rhode Island, 02818, United States
-
Viking Clinical Site #1046
Houston, Texas, 77040, United States
-
Viking Clinical Site #1047
Abilene, Texas, 79606, United States
-
Viking Clinical Site #1048
Dallas, Texas, 75235, United States
-
Viking Clinical Site #1049
Dallas, Texas, 75230, United States
-
Viking Clinical Site #1050
Long Beach, California, 90815, United States
-
Viking Clinical Site #1051
Lincoln, California, 95648, United States
-
Viking Clinical Site #1052
Spring Valley, California, 91978, United States
-
Viking Clinical Site #1053
Montclair, California, 91763, United States
-
Viking Clinical Site #1054
Huntington Park, California, 90255, United States
-
Viking Clinical Site #1055
Los Angeles, California, 90057, United States
-
Viking Clinical Site #1056
Palmetto Bay, Florida, 33157, United States
-
Viking Clinical Site #1057
West Palm Beach, Florida, 33407, United States
-
Viking Clinical Site #1058
Jacksonville, Florida, 32216, United States
-
Viking Clinical Site #1059
New Port Richey, Florida, 34652, United States
-
Viking Clinical Site #1060
Lakewood Rch, Florida, 34211, United States
-
Viking Clinical Site #1061
Morehead City, North Carolina, 28857, United States
-
Viking Clinical Site #1062
Honolulu, Hawaii, 96814, United States
-
Viking Clinical Site #1063
Austin, Texas, 78131, United States
-
Viking Clinical Site #1064
Birmingham, Alabama, 35249, United States
-
Viking Clinical Site #1065
Lebanon, New Hampshire, 03756, United States
-
Viking Clinical Site #1066
Rockville, Maryland, 20854, United States
-
Viking Clinical Site #1067
Van Nuys, California, 91405, United States
-
Viking Clinical Site #1068
Panorama City, California, 91402, United States
-
Viking Clinical Site #1069
Lexington, Kentucky, 40509, United States
-
Viking Clinical Site #1070
Escondido, California, 92025, United States
-
Viking Clinical Site #1071
Chula Vista, California, 91911, United States
-
Viking Clinical Site #1072
Renton, Washington, 98057, United States
-
Viking Clinical Site #1073
San Antonio, Texas, 78229, United States
-
Viking Clinical Site #1074
Cincinnati, Ohio, 45242, United States
-
Viking Clinical Site #1075
Omaha, Nebraska, 68134, United States
-
Viking Clinical Site #1076
Lakeland, Florida, 33803, United States
-
Viking Clinical Site #1077
Lampasas, Texas, 76550, United States
-
Viking Clinical Site #1078
Manteca, California, 95336, United States
-
Viking Clinical Site #1079
Walnut Creek, California, 94598, United States
-
Viking Clinical Site #1080
Meridian, Idaho, 83642, United States
-
Viking Clinical Site #1081
Mobile, Alabama, 36608, United States
-
Viking Clinical Site #1082
Suffolk, Virginia, 23435, United States
-
Viking Clinical Site #1083
Fort Myers, Florida, 33912, United States
-
Viking Clinical Site #1085
San Antonio, Texas, 78222, United States
-
Viking Clinical Site #1086
San Juan, 00927, Puerto Rico
-
Viking Clinical Site #1087
Monroe, Louisiana, 71201, United States
-
Viking Clinical Site #1088
Albany, New York, 12205, United States
-
Viking Clinical Site #1089
Columbus, Ohio, 43215, United States
-
Viking Clinical Site #1090
Chicago, Illinois, 60640, United States
-
Viking Clinical Site #1091
Bellaire, Texas, 77401, United States
-
Viking Clinical Site #1092
Salt Lake City, Utah, 84107, United States
-
Viking Clinical Site #1093
Savannah, Georgia, 31406, United States
-
Viking Clinical Site #1094
Chevy Chase, Maryland, 20815, United States
-
Viking Clinical Site #1095
Marlton, New Jersey, 08009, United States
-
Viking Clinical Site #1096
Hartsdale, New York, 10530, United States
-
Viking Clinical Site #1097
Portland, Oregon, 97202, United States
-
Viking Clinical Site #1098
Arlington, Virginia, 22205, United States
-
Viking Clinical Site #1099
Wichita, Kansas, 67207, United States
-
Viking Clinical Site #1101
Waco, Texas, 76710, United States
-
Viking Clinical Site #1102
Medford, Oregon, 97504, United States
-
Viking Clinical Site #1103
Boston, Massachusetts, 02114, United States
-
Viking Clinical Site #1104
Santa Maria, California, 93458, United States
-
Viking Clinical Site #1106
Lafayette, Louisiana, 70508, United States
-
Viking Clinical Site #1107
Delray Beach, Florida, 33445, United States
-
Viking Clinical Site #1108
St Louis, Missouri, 63108, United States
-
Viking Clinical Site #1109
Tustin, California, 92780, United States
-
Viking Clinical Site #1110
Morehead City, North Carolina, 28557, United States
-
Viking Clinical Site #1111
Frisco, Texas, 75033, United States
-
Viking Clinical Site #1112
DeLand, Florida, 32720, United States
-
Viking Clinical Site #1113
Norman, Oklahoma, 73069, United States
-
Viking Clinical Site #1116
Atlanta, Georgia, 30329, United States
-
Viking Clinical Site #1117
Miami, Florida, 33122, United States
-
Viking Clinical Site #1118
Baton Rouge, Louisiana, 70808, United States
-
Viking Clinical Site #1119
Denver, Colorado, 80210, United States
-
Viking Clinical Site #1120
Rincon, Georgia, 31326, United States
-
Viking Clinical Site #1121
Clearwater, Florida, 33761, United States
-
Viking Clinical Site #1122
Durham, North Carolina, 27701, United States
-
Viking Clinical Site #1123
Washington D.C., District of Columbia, 20036, United States
-
Viking Clinical Site #1124
Brownsville, Texas, 78526, United States
-
Viking Clinical Site #1125
Springfield, Missouri, 65807, United States
-
Viking Clinical Site #1126
Portland, Oregon, 97210, United States
-
Viking Clinical Site #1127
Valparaiso, Indiana, 46383, United States
-
Viking Clinical Site #1128
Huntsville, Alabama, 35801, United States
-
Viking Clinical Site #1129
Lemon Grove, California, 91945, United States
-
Viking Clinical Site #1130
Mayagüez, 00680, Puerto Rico
-
Viking Clinical Site #1131
San Diego, California, 92103, United States
-
Viking Clinical Site #1132
Rolling Hills Estates, California, 90274, United States
-
Viking Clinical Site #1133
New York, New York, 10036, United States
-
Viking Clinical Site #1134
Myrtle Beach, South Carolina, 29572, United States
-
Viking Clinical Site #1135
Scottsdale, Arizona, 85260, United States
-
Viking Clinical Site #1136
Needham, Massachusetts, 02492, United States
-
Viking Clinical Site #1137
Tulsa, Oklahoma, 74133, United States
-
Viking Clinical Site #1138
Westmont, Illinois, 60559, United States
-
Viking Clinical Site #1139
Baton Rouge, Louisiana, 70809, United States
-
Viking Clinical Site #1140
Gulfport, Mississippi, 39503, United States
-
Viking Clinical Site #1141
Charlotte, North Carolina, 28250, United States
-
Viking Clinical Site #1142
New York, New York, 10065, United States
-
Viking Clinical Site #1143
San Antonio, Texas, 78215, United States
-
Viking Clinical Site #1144
Fayetteville, North Carolina, 28304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?